• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Advisory Committees

  • Print
  • Share
  • E-mail
-

2013 Advisory Committee Tentative Meetings

The annual publication of tentatively scheduled advisory committee meetings will provide both advisory committee members and the public with the opportunity, in advance, to schedule attendance at FDA's upcoming advisory committee meetings. Changes to this list will be posted on this site.  FDA will continue to publish a Federal Register notice 15 days in advance of each upcoming advisory committee meeting, to announce the meeting (21 CFR 14.20).

The following list announces FDA's tentatively scheduled advisory committee meetings for 2013.  You may also obtain up-to-date information by calling the Advisory Committee Information Line 1-800-741-8138 (301-443-0572 in the Washington, DC area). 


Committee Name

 

Tentative Date(s) of Meeting(s)

OFFICE OF THE COMMISSIONER

Pediatric Advisory Committee

March 14-15, September 19-20

Risk Communication Advisory Committee

April 29-30,

August 15-16, December 16-17

Science Board to FDA

February 27, June 24, November 20

CENTER FOR BIOLOGICS EVALUATION AND RESEARCH

Allergenic Products Advisory Committee

November 5-6

Blood Products Advisory Committee

February 12-13, April 8-9,

August 1-2

Cellular, Tissue and Gene Therapies Advisory Committee

January 15, April 17-18, June 27-28,

October 24-25

Transmissible Spongiform Encephalopathies Advisory Committee

March 14-15

Vaccines and Related Biological Products Advisory Committee

February 27, May 8-9 or July 17-18

(Backup date), September 18-19,

November 13-14

CENTER FOR DRUG EVALUATION AND RESEARCH

Anesthetic and Analgesic Drug Products Advisory Committee

May 

Anti-Infective Drugs Advisory Committee

 

Date(s), if needed,

to be determined

Antiviral Drugs Advisory Committee

May and October dates

to be determined

Arthritis Advisory Committee

July or August and fall dates

to be determined

 

Cardiovascular and Renal Drugs Advisory Committee

 

August and other date(s)

to be determined

Dermatologic and Ophthalmic Drugs Advisory Committee

Date(s), if needed,

to be determined

Drug Safety and Risk Management Advisory Committee

 

Endocrinologic and Metabolic Drugs Advisory Committee

June, July, and

August dates

to be determined

Gastrointestinal Drugs Advisory Committee

March 19 and other date(s)

to be determined

Medical Imaging Drugs Advisory Committee

February 14 and May date

to be determined

Nonprescription Drugs Advisory Committee

Date(s), if needed, t

o be determined

Oncologic Drugs Advisory

Committee

May, June, July,

September date(s) to be determined

Pharmacy Compounding Drugs Advisory Committee

Date(s), if needed,

to be determined

Peripheral and Central Nervous System Drugs Advisory Committee

May 22

Advisory Committee for Pharmaceutical Science and Clinical Pharmacology

Date(s), if needed,

to be determined

Psychopharmacologic Drugs Advisory Committee

 

Pulmonary‑Allergy Drugs Advisory Committee

March 7

Advisory Committee for Reproductive Health Drugs

March 4, July 9

 

CENTER FOR DEVICES AND RADIOLOGICAL HEALTH

Medical Devices Advisory Committee (Comprised of 18 Panels)

Anesthesiology and Respiratory Therapy Devices Panel

Date(s), if needed, to be determined

Circulatory System Devices Panel

March 22, May 17, May 24, June 27,

September 27, November 22

Clinical Chemistry and Clinical Toxicology Devices Panel

April 25-26

Dental Products Panel

June 18

Ear, Nose, and Throat Devices Panel

July 12

Gastroenterology-Urology Devices Panel

 May 16, June 27

General and Plastic Surgery Devices Panel

May 2, June 26

General Hospital and Personal Use Devices Panel

June 28, August 30

Hematology and Pathology Devices Panel

Date(s), if needed,

to be determined

Immunology Devices Panel

Date(s), if needed,

to be determined

Medical Devices Dispute Resolution Panel

Date(s), if needed,

to be determined

Microbiology Devices Panel

June 13

Molecular and Clinical Genetics Panel

September 13

Neurological Devices Panel

February 22

Obstetrics and Gynecology Devices Panel

September 20

Ophthalmic Devices Panel

April 18, June 14, August 23

Orthopaedic and Rehabilitation Devices Panel

April 5, May 10, September 26

Radiological Devices Panel

September 12

Device Good Manufacturing Practice Advisory Committee

April 11

National Mammography Quality Assurance Advisory Committee

October 25

Technical Electronic Product Radiation Safety Standards Committee

Date(s), if needed,

to be determined

CENTER FOR FOOD SAFETY AND APPLIED NUTRITION

Food Advisory Committee

July 15-16, August 29-30,

September 23-24

CENTER FOR TOBACCO PRODUCTS

Tobacco Products Scientific Advisory Committee

April 30-May 1

CENTER FOR VETERINARY MEDICINE

Veterinary Medicine Advisory Committee

Date(s), if needed,

to be determined

NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH (NCTR)

Science Advisory Board to NCTR

December 10-11

 

-
-